Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sorting out the risks in progressive multifocal leukoencephalopathy.
Calabrese LH, Molloy E, Berger J. Calabrese LH, et al. Nat Rev Rheumatol. 2015 Feb;11(2):119-23. doi: 10.1038/nrrheum.2014.167. Epub 2014 Oct 14. Nat Rev Rheumatol. 2015. PMID: 25314016 Review.
Therapy: Targeted but not trouble-free: efalizumab and PML.
Molloy ES, Calabrese LH. Molloy ES, et al. Nat Rev Rheumatol. 2009 Aug;5(8):418-9. doi: 10.1038/nrrheum.2009.142. Nat Rev Rheumatol. 2009. PMID: 19648939
Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial.
Conway R, O'Neill L, Gallagher P, McCarthy GM, Murphy CC, Veale DJ, Fearon U, Molloy ES. Conway R, et al. Among authors: molloy es. Semin Arthritis Rheum. 2018 Dec;48(3):523-528. doi: 10.1016/j.semarthrit.2018.04.004. Epub 2018 Apr 22. Semin Arthritis Rheum. 2018. PMID: 29776658
56 results
Jump to page
Feedback